3 April 2016

Mesenchymale stamceltherapie voor boezemfibrilleren: een nieuw antwoord op een groeiende pandemie?

Mesenchymale stamceltherapie voor boezemfibrilleren: een nieuw antwoord op een groeiende pandemie?

The Heart Center in Leiden, which is part of the Leiden University Medical Center, is launching an investigation into the frequently occurring cardiac arrhythmia atrial fibrillation. In this project, the therapeutic potential of human chymal stem cells which have been derived from patients with atrial fibrillation is being investigated. Ammodo supports this research in order to contribute to the further research into the treatment of cardiac arrhythmia atrial fibrillation.

lumc.nl

Dr. Rupamanjari Majumder, Computersimulation van of normal hart activity (left) and of disturbed activity: cardiac arrhytmia (right)